Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 27% ± 9% |
Insufficient scRNA-seq data for expression of POFUT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 3522.98 | 180 / 180 | 100% | 57.10 | 430 / 430 |
esophagus | 100% | 2717.78 | 1444 / 1445 | 100% | 63.69 | 183 / 183 |
breast | 100% | 3342.69 | 459 / 459 | 100% | 57.75 | 1117 / 1118 |
lung | 100% | 2744.13 | 578 / 578 | 100% | 48.62 | 1153 / 1155 |
stomach | 100% | 2158.18 | 359 / 359 | 100% | 85.61 | 285 / 286 |
intestine | 100% | 3387.21 | 966 / 966 | 100% | 78.15 | 525 / 527 |
skin | 100% | 4454.90 | 1809 / 1809 | 100% | 57.64 | 470 / 472 |
prostate | 100% | 2747.40 | 245 / 245 | 99% | 39.41 | 499 / 502 |
kidney | 100% | 2648.93 | 89 / 89 | 99% | 42.96 | 894 / 901 |
uterus | 100% | 3446.68 | 170 / 170 | 99% | 44.71 | 454 / 459 |
thymus | 100% | 3441.08 | 653 / 653 | 99% | 34.48 | 598 / 605 |
bladder | 100% | 3505.10 | 21 / 21 | 99% | 50.23 | 497 / 504 |
pancreas | 100% | 1888.16 | 327 / 328 | 98% | 34.61 | 175 / 178 |
brain | 98% | 1157.04 | 2591 / 2642 | 100% | 43.89 | 704 / 705 |
liver | 100% | 3705.83 | 226 / 226 | 97% | 38.63 | 395 / 406 |
adrenal gland | 100% | 2602.31 | 258 / 258 | 95% | 26.96 | 218 / 230 |
adipose | 100% | 3278.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3532.10 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1978.02 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 45.27 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.60 | 1 / 1 |
muscle | 100% | 1803.67 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2448.45 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 29.27 | 77 / 80 |
lymph node | 0% | 0 | 0 / 0 | 93% | 19.30 | 27 / 29 |
peripheral blood | 57% | 1068.78 | 530 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016266 | Biological process | O-glycan processing |
GO_0001525 | Biological process | angiogenesis |
GO_0008593 | Biological process | regulation of Notch signaling pathway |
GO_0001756 | Biological process | somitogenesis |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0006004 | Biological process | fucose metabolic process |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0007399 | Biological process | nervous system development |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0007507 | Biological process | heart development |
GO_0036066 | Biological process | protein O-linked fucosylation |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
GO_0046922 | Molecular function | peptide-O-fucosyltransferase activity |
GO_0008417 | Molecular function | fucosyltransferase activity |
Gene name | POFUT1 |
Protein name | GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 1) (O-FucT-1) Protein O-fucosyltransferase 1 GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 1) |
Synonyms | KIAA0180 FUT12 |
Description | FUNCTION: Catalyzes the reaction that attaches fucose through an O-glycosidic linkage to a conserved serine or threonine residue found in the consensus sequence C2-X(4,5)-[S/T]-C3 of EGF domains, where C2 and C3 are the second and third conserved cysteines. Specifically uses GDP-fucose as donor substrate and proper disulfide pairing of the substrate EGF domains is required for fucose transfer. Plays a crucial role in NOTCH signaling. Initial fucosylation of NOTCH by POFUT1 generates a substrate for FRINGE/RFNG, an acetylglucosaminyltransferase that can then extend the fucosylation on the NOTCH EGF repeats. This extended fucosylation is required for optimal ligand binding and canonical NOTCH signaling induced by DLL1 or JAGGED1. Fucosylates AGRN and determines its ability to cluster acetylcholine receptors (AChRs). . |
Accessions | A0A9L9PY15 Q9H488 ENST00000706472.1 ENST00000375749.8 [Q9H488-1] ENST00000375730.3 [Q9H488-2] ENST00000706471.1 A0A9L9PX68 |